Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy. (March 2019)

• Record Type: Journal Article
• Authors: Parikh, Victoria N.; Caleshu, Colleen; Reuter, Chloe; Lazzeroni, Laura C.; Ingles, Jodie; Garcia, John; McCaleb, Kristen; Adesiyun, Tolulope; Sedaghat-Hamedani, Farbod; Kumar, Saurabh; Graw, Sharon; Gigli, Marta; Stolfo, Davide; Dal Ferro, Matteo; Ing, Alexander Y.; Nussbaum, Robert; Funke, Birgit; Wheeler, Matthew T.; Hershberger, Ray E.; Cook, Stuart; Steinmetz, Lars M.; Lakdawala, Neal K.; Taylor, Matthew R.G.; Mestroni, Luisa; Merlo, Marco; Sinagra, Gianfranco; Semsarian, Christopher; Meder, Benjamin; Judge, Daniel P.; Ashley, Euan
• Is Part Of: Circulation. Volume 12:Number 3(2019)
• Publication Date: 2019-03
• Subjects: arrhythmias, cardiac -- cardiomyopathies -- genetics -- RNA splicing; Heart failure -- Periodicals; 616.129005
• DOI: 10.1161/CIRCHEARTFAILURE.118.005371
• Languages: English
• ISSNs: 1941-3289

Abstract

Abstract : Background: Variants in the cardiomyocyte-specific RNA splicing factor RBM20 have been linked to familial cardiomyopathy, but the causative genetic architecture and clinical consequences of this disease are incompletely defined. Methods and Results: To define the genetic architecture of RBM20 cardiomyopathy, we first established a database of RBM20 variants associated with cardiomyopathy and compared these to variants observed in the general population with respect to their location in the RBM20 coding transcript. We identified 2 regions significantly enriched for cardiomyopathy-associated variants in exons 9 and 11. We then assembled a registry of 74 patients with RBM20 variants from 8 institutions across the world (44 index cases and 30 from cascade testing). This RBM20 patient registry revealed highly prevalent family history of sudden cardiac death (51%) and cardiomyopathy (72%) among index cases and a high prevalence of composite arrhythmias (including atrial fibrillation, nonsustained ventricular tachycardia, implantable cardiac defibrillator discharge, and sudden cardiac arrest, 43%). Patients harboring variants in cardiomyopathy-enriched regions identified by our variant database analysis were enriched for these findings. Further, these characteristics were more prevalent in the RBM20 registry than in large cohorts of patients with dilated cardiomyopathy and TTNtv cardiomyopathy and not significantly different from a cohort of patients with LMNA -associated cardiomyopathy. Conclusions: Our data establish RBM20 cardiomyopathy as a highly penetrant and arrhythmogenic cardiomyopathy. These findings underline the importance of arrhythmia surveillance and family screening in this disease and represent the first step in defining the genetic architecture of RBM20 disease causality on a population level. Abstract : Supplemental Digital Content is available in the text.